cadema corp said entered letter intent with national underwriting firm for offering five mln dlrs worth convertible preferred stock cadema said will file registration statement with securities and exchange commission later this month for offering proceeds will used fund clinical trials for company treatments for rheumatoid arthritis and metastatic bone cancer also said increased size its board six from five members reuter 